Drugs Made In America Acquisition II
DMII · NASDAQ
$10.19+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Who owns DMII
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 37.0% of DMII’s shares.
- Drugs Made In America Acquisition II LLC4.6%
- Karpus Investment Management4.4%
- Magnetar Capital Partners LP4.2%
- MMCAP Asset Management4.2%
- Next 6 largest institutions19.5%
- All other shareholders63.0%
| Holder | Shares | % of shares |
|---|---|---|
| Drugs Made In America Acquisition II LLC | 2.96M | 4.64% |
| Karpus Investment Management | 2.79M | 4.38% |
| Magnetar Capital Partners LP | 2.70M | 4.24% |
| MMCAP Asset Management | 2.70M | 4.24% |
| Glazer Capital, LLC | 2.34M | 3.68% |
| Highbridge Capital Management, LLC | 2.24M | 3.52% |
| Conaway (Charles C.) | 2.00M | 3.14% |
| Millennium Management LLC | 1.99M | 3.13% |
| Hudson Bay Capital Management LP | 1.97M | 3.09% |
| Wolverine Asset Management, LLC | 1.86M | 2.91% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| CrossingBridge Low Duration High Yield Fund | 1.07M | 1.69% |
| First Trust Merger Arbitrage Fund | 913.21K | 1.43% |
| PICTON Arbitrage Plus Alternative Fund | 720.20K | 1.13% |
| Merger Fund | 411.75K | 0.65% |
| First Trust Multi-Strategy Fund | 142.64K | 0.22% |
Short interest
Settled Sep 30, 2026
- Shares short
- 121.55K
- Days to cover
- 2.11
- % of shares outstanding
- 0.19%
- Average daily volume
- 57.56K
- Change since last report
- −3.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.